Literature DB >> 10527772

Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties.

K E Schlageter1, P Molnar, G D Lapin, D R Groothuis.   

Abstract

We studied microvessel organization in five brain tumor models (ENU, MSV, RG-2, S635cl15, and D-54MG) and normal brain, including microvessel diameter (LMVD), intermicrovessel distance (IMVD), microvessel density (MVD), surface area (S(v)), and orientation. LMVD and IMVD were larger and MVD was lower in tumors than normal brain. S(v) in tumors overlapped normal brain values and orientation was random in both tumors and brain. ENU and RG-2 tumors and brain were studied by electron microscopy. Tumor microvessel wall was thicker than that of brain. ENU and normal brain microvessels were continuous and nonfenestrated. RG-2 microvessels contained fenestrations and endothelial gaps; the latter had a maximum major axis of 3.0 microm. Based on anatomic measurements, the pore area of RG-2 tumors was estimated at 7.4 x 10(-6) cm(2) g(-1) from fenestrations and 3.5 x 10(-5) cm(2) g(-1) from endothelial gaps. Increased permeability of RG-2 microvessels to macromolecules is most likely attributable to endothelial gaps. Three microvessel populations may occur in brain tumors: (1) continuous nonfenestrated, (2) continuous fenestrated, and (3) discontinuous (with or without fenestrations). The first group may be unique to brain tumors; the latter two are similar to microvessels found in systemic tumors. Since structure-function properties of brain tumor microvessels will affect drug delivery, studies of microvessel function should be incorporated into clinical trials of brain tumor therapy, especially those using macromolecules. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527772     DOI: 10.1006/mvre.1999.2188

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  83 in total

1.  How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging.

Authors:  Adriana T Perles-Barbacaru; Boudewijn P J van der Sanden; Regine Farion; Hana Lahrech
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-09       Impact factor: 6.200

Review 2.  Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.

Authors:  Linfeng Wu; Xiaoxun Li; Dileep R Janagam; Tao L Lowe
Journal:  Pharm Res       Date:  2013-08-31       Impact factor: 4.200

3.  Targeted delivery of proteins across the blood-brain barrier.

Authors:  Brian J Spencer; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

Review 4.  Diffusion in brain extracellular space.

Authors:  Eva Syková; Charles Nicholson
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

5.  Engineered nanoparticles for systemic siRNA delivery to malignant brain tumours.

Authors:  Johan Karlsson; Yuan Rui; Kristen L Kozielski; Amanda L Placone; Olivia Choi; Stephany Y Tzeng; Jayoung Kim; Jamal J Keyes; Max I Bogorad; Kathleen Gabrielson; Hugo Guerrero-Cazares; Alfredo Quiñones-Hinojosa; Peter C Searson; Jordan J Green
Journal:  Nanoscale       Date:  2019-10-15       Impact factor: 7.790

6.  Role of cholinergic system and calcium synchronization in schizophrenia.

Authors:  Atmaram Yarlagadda; Anita H Clayton
Journal:  Psychiatry (Edgmont)       Date:  2009-04

Review 7.  Nanoparticles for imaging and treating brain cancer.

Authors:  Joseph D Meyers; Tennyson Doane; Clemens Burda; James P Basilion
Journal:  Nanomedicine (Lond)       Date:  2013-01       Impact factor: 5.307

8.  Dynamic model for the tissue concentration and oxygen saturation of hemoglobin in relation to blood volume, flow velocity, and oxygen consumption: Implications for functional neuroimaging and coherent hemodynamics spectroscopy (CHS).

Authors:  Sergio Fantini
Journal:  Neuroimage       Date:  2013-04-10       Impact factor: 6.556

9.  Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells.

Authors:  Hemant Sarin; Ariel S Kanevsky; Haitao Wu; Kyle R Brimacombe; Steve H Fung; Alioscka A Sousa; Sungyoung Auh; Colin M Wilson; Kamal Sharma; Maria A Aronova; Richard D Leapman; Gary L Griffiths; Matthew D Hall
Journal:  J Transl Med       Date:  2008-12-18       Impact factor: 5.531

10.  Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.

Authors:  Hemant Sarin; Ariel S Kanevsky; Haitao Wu; Alioscka A Sousa; Colin M Wilson; Maria A Aronova; Gary L Griffiths; Richard D Leapman; Howard Q Vo
Journal:  J Transl Med       Date:  2009-06-23       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.